Weight loss drugs may offer a new avenue for bipolar disorder research

Glucagon-like peptide 1 receptor agonists (GLP-1RA), commonly used to treat diabetes and weight loss, may have additional mental health benefits, especially for people with bipolar disorder, new Griffith University research has found.